GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.
Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...
GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.
Related Articles
Huachu Securities: Shunfeng (06936) continues to lead in the volume growth rate in June, pay attention to investment opportunities in the express delivery sector under the "anti-inner loop" trend.
Guosen: How to make absolute return investments in a low interest rate environment?
Preview of new stocks in the US stock market | Industry anti-involvement helps to repair the fundamentals, how does New Subee Optoelectronics (XZ.US) break into the top tier of the industry?
Huachu Securities: Shunfeng (06936) continues to lead in the volume growth rate in June, pay attention to investment opportunities in the express delivery sector under the "anti-inner loop" trend.
Guosen: How to make absolute return investments in a low interest rate environment?
Preview of new stocks in the US stock market | Industry anti-involvement helps to repair the fundamentals, how does New Subee Optoelectronics (XZ.US) break into the top tier of the industry?
RECOMMEND
For the Third Consecutive Month, China Reduces U.S. Treasury Holdings by $900 Million in May, While Japan and the United Kingdom Increase Holdings
18/07/2025
Tariff-Driven Inflation Arrives with Delay as U.S. Consumers Begin to Feel the Initial Pinch
18/07/2025
Multiple Countries in High-Stakes Talks with the U.S.; EU Considers Invoking “Anti-Coercion Tool” as U.S. Plans Unified Tariffs on 150 Nations
18/07/2025
